نتائج البحث - "Lord-Bessen, J."

1

Academic Journal

المؤلفون: Dinardo, CD, Montesinos, P, Schuh, AC, Papayannidis, C, Vyas, P, Wei, AH, Zeidan, AM, Chen, C, Lord-Bessen, J, Yu, P, Shi, L, Guo, S, Bluemmert, I, Yu, X, Hasan, M, Martin Regueira, P, De Botton, S

Relation: https://ora.ox.ac.uk/objects/uuid:b327eb0e-cd02-4db8-bfa9-c2cf0e4f93f0; https://doi.org/10.1200/jco.2022.40.16_suppl.7032

الاتاحة: https://doi.org/10.1200/jco.2022.40.16_suppl.7032
https://ora.ox.ac.uk/objects/uuid:b327eb0e-cd02-4db8-bfa9-c2cf0e4f93f0

View record in BASE

2

Academic Journal

Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients with Relapsed/Refractory Multiple Myeloma: Final Data from the Phase 2 ELOQUENT-3 Trial

المؤلفون: Weisel K., Dimopoulos M. A., San-Miguel J., Paner A., Engelhardt M., Taylor F., Lord-Bessen J., Yip C., Greenwood M., Tang J., Cavo M.

المساهمون: Weisel K., Dimopoulos M.A., San-Miguel J., Paner A., Engelhardt M., Taylor F., Lord-Bessen J., Yip C., Greenwood M., Tang J., Cavo M.

مصطلحات موضوعية: Elotuzumab Plus Pomalidomide, Dexamethasone, Relapsed/Refractory, Multiple Myeloma Phase 2 ELOQUENT-3 Trial

وصف الملف: ELETTRONICO

Relation: info:eu-repo/semantics/altIdentifier/pmid/36860268; volume:7; issue:3; firstpage:1; lastpage:7; numberofpages:7; journal:HEMASPHERE; https://hdl.handle.net/11585/957709; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85149259613; https://journals.lww.com/hemasphere/fulltext/2023/03000/impact_of_elotuzumab_plus.14.aspx

الاتاحة: https://hdl.handle.net/11585/957709
https://doi.org/10.1097/HS9.0000000000000843
https://journals.lww.com/hemasphere/fulltext/2023/03000/impact_of_elotuzumab_plus.14.aspx

View record in BASE

3

Academic Journal

Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspatercept

المؤلفون: Cappellini, MD, Taher, AT, Piga, A, Shah, F, Voskaridou, E, Viprakasit, V, Porter, JB, Hermine, O, Neufeld, EJ, Thompson, AA, Tang, D, Yucel, A, Lord-Bessen, J, Yu, P, Guo, S, Shetty, JK, Miteva, D, Zinger, T, Backstrom, JT, Oliva, EN

المصدر: European Journal of Haematology , 111 (1) pp. 113-124. (2023)

مصطلحات موضوعية: beta-thalassemia, iron overload, quality of life

وصف الملف: text

Relation: https://discovery.ucl.ac.uk/id/eprint/10169805/1/Porter_European%20J%20of%20Haematology%20-%202023%20-%20Cappellini%20-%20Health%E2%80%90related%20quality%20of%20life%20in%20patients%20with%20%20%E2%80%90thalassemia%20%20Data%20from.pdf; https://discovery.ucl.ac.uk/id/eprint/10169805/

الاتاحة: https://discovery.ucl.ac.uk/id/eprint/10169805/1/Porter_European%20J%20of%20Haematology%20-%202023%20-%20Cappellini%20-%20Health%E2%80%90related%20quality%20of%20life%20in%20patients%20with%20%20%E2%80%90thalassemia%20%20Data%20from.pdf
https://discovery.ucl.ac.uk/id/eprint/10169805/

View record in BASE

4

Academic Journal

P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY

المؤلفون: van de Donk, N. W., Guo, S., Shi, L., Lord-Bessen, J., Tang, D., Karlin, L., Weisel, K., Ramasamy, K., Abad, P. C., Amin, A., Amin, S., Lonial, S.

المصدر: HemaSphere ; volume 6, page 1620-1621 ; ISSN 2572-9241

الاتاحة: http://dx.doi.org/10.1097/01.hs9.0000849812.21433.44
https://journals.lww.com/10.1097/01.HS9.0000849812.21433.44

View record in BASE

5

Academic Journal

P39 The Humanistic Burden of Transfusion-Dependent Lower-Risk Myelodysplastic Syndromes on Patients and Caregivers: Qualitative Research Findings

المؤلفون: Díez Campelo, M., Yucel, A., Lord-Bessen, J., Wayser, G., Beusterien, K., DeCongelio, M., Bulkley, A., Iraca, TA., Hassan, AA., Hughes, C., Park, S.

المصدر: Value in Health ; volume 25, issue 7, page S295 ; ISSN 1098-3015

الاتاحة: http://dx.doi.org/10.1016/j.jval.2022.04.051
https://api.elsevier.com/content/article/PII:S1098301522002510?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1098301522002510?httpAccept=text/plain

View record in BASE

6

Academic Journal

Fedratinib improves myelofibrosis-related symptoms and health-related quality of life in patients with myelofibrosis previously treated with ruxolitinib: patient-reported outcomes from the phase II JAKARTA2 trial

المؤلفون: Harrison C. N., Schaap N., Vannucchi A. M., Kiladjian J. -J., Jourdan E., Silver R. T., Schouten H. C., Passamonti F., Zweegman S., Talpaz M., Verstovsek S., Tang D., Abraham P., Lord-Bessen J., Rose S., Guo S., Liao W., Mesa R. A.

المساهمون: Harrison, C. N., Schaap, N., Vannucchi, A. M., Kiladjian, J. -J., Jourdan, E., Silver, R. T., Schouten, H. C., Passamonti, F., Zweegman, S., Talpaz, M., Verstovsek, S., Tang, D., Abraham, P., Lord-Bessen, J., Rose, S., Guo, S., Liao, W., Mesa, R. A.

وصف الملف: ELETTRONICO

Relation: info:eu-repo/semantics/altIdentifier/pmid/33969275; info:eu-repo/semantics/altIdentifier/wos/WOS:000647642200009; volume:5; issue:5; lastpage:1; numberofpages:11; journal:HEMASPHERE; https://hdl.handle.net/11383/2143460; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85105717345

الاتاحة: https://hdl.handle.net/11383/2143460
https://doi.org/10.1097/HS9.0000000000000562

View record in BASE

7

Academic Journal

Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Placebo-controlled, Phase III JAKARTA Trial

المؤلفون: Mesa R. A., Schaap N., Vannucchi A. M., Kiladjian J. -J., Passamonti F., Zweegman S., Talpaz M., Verstovsek S., Rose S., Abraham P., Lord-Bessen J., Tang D., Guo S., Ye X., Harrison C. N.

المساهمون: R.A. Mesa, N. Schaap, A.M. Vannucchi, J.-. Kiladjian, F. Passamonti, S. Zweegman, M. Talpaz, S. Verstovsek, S. Rose, P. Abraham, J. Lord-Bessen, D. Tang, S. Guo, X. Ye, C.N. Harrison

مصطلحات موضوعية: Settore MED/15 - Malattie del Sangue

Relation: info:eu-repo/semantics/altIdentifier/pmid/33969273; info:eu-repo/semantics/altIdentifier/wos/WOS:000647642200001; volume:5; issue:5; firstpage:1; lastpage:10; numberofpages:10; journal:HEMASPHERE; https://hdl.handle.net/2434/997149; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85105757863

الاتاحة: https://hdl.handle.net/2434/997149
https://doi.org/10.1097/HS9.0000000000000553

View record in BASE